VELOX GmbH is delighted to announce its new distribution partnership with Repsol, one of the leading polyolefin producers in Europe.
VELOX will be distributing medical polyolefins of the new Repsol Healthcare® brand (Polypropylene (PP), Polyethylene (PE) and Ethylene Vinyl Acetate (EVA)) for pharmaceutical packaging and medical devices in the following countries: Austria, Belarus, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Luxemburg, Malta, Netherlands, Norway, Poland, Romania, Russia, Slovakia, Sweden, Switzerland, Turkey, Ukraine and United Kingdom.
Through these medical polyolefins VELOX is in the position to offer its customers a more complete and holistic product range for the production of their medical applications. The products meet European & US Pharmacopoeias (USP/EP) requirements which underlines Repsol’s long-term guarantee, commitment, service and compliance within the Healthcare industry. VELOX’ experienced and dedicated medical sales team is pleased to provide high-level technical and commercial advice to integrate these new products combined with the existing medical portfolio into the customer’s value chain.